The ε4 allele of APOE confers the greatest genetic risk for Alzheimer disease (AD), and recent data implicate brain-iron load as a pathogenic mechanism because ε4 carriage elevates the level of cerebrospinal fluid (CSF) ferritin. Baseline CSF levels of Aβ1-42, tau, APOE, ferritin, factor H (an inflammation marker), and hemoglobin (a blood leakage marker) were analyzed as previously described.
Results | In participants who, at baseline, were cognitively normal or were categorized as having MCI, CSF ferritin level predicted cognition in a 4-way interaction with time, APOE-ε4, and diagnosis (RAVLT: β [SE] = −1.45 [0.60], P = .02; ADAS-Cog13: β [SE] = 0.14 [0.07], P = .03) (Table) . In contrast, the tau/Aβ1-42 ratio interacted with time and not APOE-ε4, diagnosis, CSF ferritin levels, or APOE levels, to predict cognitive performance (RAVLT: In separate modeling of cognitively normal individuals and those with MCI , the tau/Aβ1-42 ratio predicted cognitive dete- Discussion | These findings demonstrate the potential for CSF ferritin as a biomarker, especially for ε4 carriers, and also provide new insight into the pathophysiologic mechanisms of AD. Cerebrospinal ferritin level might potentially be affected by abnormal vascular permeability, which occurs early in AD. 5 However, in our model of the relationship between paired CSF and plasma samples from this cohort, plasma ferritin levels accounted for only 4% of the variance of CSF ferritin levels, regardless of diagnosis. 1 Thus, plasma ferritin permeating into CSF is unlikely to explain the adverse prognosis associated with higher CSF ferritin levels. Rather, CSF ferritin level probably reflects brain-iron burden (analogous to the periphery). Our observation that ferritin had a markedly divergent impact on ε4 carriers and noncarriers agrees with findings of prior genetic studies demonstrating an epistatic interaction between the APOE-ε4 allele and the iron-accumulating H63D variant of the hemochromatosis protein, HFE, leading to earlier onset of AD (by 5.5 years) (Ali-Rahmani et al 6 ). Therefore, while CSF ferritin level is an indirect measure of ferritin level in the brain, our findings are consistent with a role for iron in the pathogenesis of AD. This interaction variable was simplified to lower-order terms when the cohort was restricted according to the column titles (ie, the diagnosis interaction variable was removed when MCI and CN were modeled separately.
The ε4 interaction variable was removed when performing separate modeling for ε4-positive and ε4-negative patients). 
Use of Genetic Testing in Amyotrophic Lateral Sclerosis by Neurologists
There have been a number of publications describing the important role of genetic counseling in amyotrophic lateral sclerosis (ALS). 1, 2 While such attempts at guiding who should undergo genetic testing are welcome, they are put forth in a vacuum because there are no data on where ALS neurologists stand in terms of genetic testing and counseling for the disease, and in terms of what is considered to be familial and sporadic ALS. 3 We attempted to fill this gap by surveying members of the Northeast Amyotrophic Lateral Sclerosis Consortium (NEALS, http://www.alsconsortium.org), one of the largest clinical research organizations for ALS. We sought to understand in which situations genetic testing is used, which genes are tested for, and the attitudes of respondents toward genetic testing and counseling.
Methods | The survey was sent via email on June 20, 2016, to 134 principal investigators who are members of NEALS. The deadline for survey completion was July 29, 2016. Data were collated and analyzed using Microsoft Excel (Table) . The NIH Office of Human Subjects Research Protection has determined that this type of research falls under exemption for institutional review board approval. 
